trending Market Intelligence /marketintelligence/en/news-insights/trending/s0pgjp5h7b4wflrenfgzqg2 content esgSubNav
In This List

Natus board approves $30M share repurchase program

Case Study

Identifying PPE Suppliers During the Pandemic

Blog

Highlighting the Top Regional Aftermarket Research Brokers by Sector Coverage

Video

COVID-19 Impact & Recovery: Healthcare Outlook for H2 2021

Blog

Corporate Credit Risk Trends in Developing Markets: A Loss Given Default (LGD) Perspective


Natus board approves $30M share repurchase program

The Natus Medical Inc. board authorized the repurchase of up to $30 million of the company's common shares.

The Pleasanton, Calif.-based healthcare distributor will use cash on hand, cash generated from operations, as well as existing credit facilities or other financing to fund the transaction.

As of Dec. 31, 2017, the company had cash and cash equivalents of approximately $89 million and availability under an existing line of credit of $70 million.

The share repurchase program is set to expire Feb. 26, 2019.